Skip to content

Neurofeedback with Gait imagery for PD

Randomized multicenter trial for investigating effect of neurofeedback with gait imagery training on Parkinson's disease patients

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs062220027
Enrollment
50
Registered
2022-06-08
Start date
2023-01-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease Parkinson's disease, gait impairment, Freezing of G ait

Interventions

In This study, participants asked to perform motor imagery training with neurofeedback, which provided as visual indicator based on the brain activities measured by the near-infrared spectroscopy medi
Neurofeedback , motor imagery

Sponsors

Mihara Masahito
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) patients who had written informed consent 2) age older than 39 year old 3) PD patients with diagnosis of clinically probable or clinically established PD in MDS criteria 4) Patients with Hoehn-Yahr stage 2 to 4 5) Patients who can walk 10 m safely with or without aid 6) Patients whose anti-Parkinsonian drug is not changed for at least 2 months at the time of registration 7) Patients who can understand the verbal order and perform task

Exclusion criteria

Exclusion criteria: 1) moderate to severe dmentia with MMSE score90%) 5) Patients wiht history of neurosurgical operation including Deep brain stimulation and trans-arterialaneurysm coil embolization) 6) Patients unstable in vital signs 7) Patients with corrected binocular visual acuity less than 1/20 8) Patients with scalp lesion which needed treatment 9) Women with Pregnancy, lactating, or suspected pregnancy 10) Patients who is unable to perform brain MRI scannning 11) Patients with past or current history of clinically established psychological illness (needs wnti-psychotic drugs). 12) Patients have experienced experimental brain stimulation intervention (including repetitive trans cranial magnetic stimuration or transcranial direct/alternative current stimulation) within 6 months prior to the enrollment. 13) Patients with severe, unpredicable wearing-off which disturb stable evaluation in each visit 14) Patients with muscloskeltal complication which affect gait performance 15) Patients assumed to be inadequate fore enrollment by their attending physician

Design outcomes

Primary

MeasureTime frame
10m walk test

Secondary

MeasureTime frame
10m walk test, MDS-UPDRS, Mini-BESTest, 3m-Timued Up and Go test, FOGQ, PDQ8, number of falls, any adverse effect

Contacts

Public ContactMasahito Mihara

Kawasaki Medical School Hospital

mihara@med.kawasaki-m.ac.jp+81-86-462-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026